EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

FABP3, a Candidate Biomarker of Muscle Strength and Myositis Disease Activity in Patients with Idiopathic Inflammatory Myopathies

Dorottya Szinay iD, Katalin Szabó iD, Tibor Béldi, Viktor Bencs, Sára Csiha, Béla Nagy iD, Hajnalka Lőrincz iD, Mariann Harangi iD, Zoltán Griger iD, Melinda Nagy-Vincze iD

Biomolecules · 2026

DOI: 10.3390/biom16101518 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, 2026. Verfasst von Dorottya Szinay und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Clinical Immunology, Department of Internal Medicine, Faculty of Medicine, University of Debrecen, H-4032 Debrecen, Hungary. Hauptthemen laut MEDLINE: Fatty Acid Binding Protein 3, Muscle Strength, Myositis. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Identifying novel, reliable blood-based biomarkers is essential to better assess disease activity in idiopathic inflammatory myopathies (IIMs). We aimed to determine serum fatty acid binding protein 3 (FABP3) levels in IIM patients and evaluated their correlations with disease activity, muscle strength, and conventional biomarkers.

Methods

This cross-sectional study enrolled 80 patients with IIM (49% polymyositis, 51% dermatomyositis) and 47 gender-matched healthy controls. Disease activity was evaluated using the IMACS core set measures, and serum FABP3 levels were determined via ELISA.

Results

FABP3 levels significantly correlated with creatine kinase (CK; r = 0.42, p < 0.001), high-sensitive C-reactive protein (hsCRP; r = 0.35, p = 0.002), and physician global disease activity (PhG; r = 0.28, p = 0.013), while showing a strong negative correlation with manual muscle testing (MMT; r = −0.39, p = 0.0005). Conversely, CK and hsCRP failed to correlate with disease activity or muscle strength. Statistical analysis confirmed that FABP3 is an independent predictor of muscle strength, and correlates with PhG better than CK in patients with chronic myositis.

Conclusions

FABP3 is a promising biomarker for IIM disease activity, which may enable more effective therapeutic decision-making in clinical practice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fatty Acid Binding Protein 3Muscle StrengthMyositisHumansFemaleMaleBiomarkersMiddle AgedCross-Sectional StudiesAdultC-Reactive ProteinAgedCreatine KinaseCase-Control Studies

Stichwörter der Autor:innen

dermatomyositisdisease activity markerfatty acid binding protein 3polymyositis

Substanzen

BiomarkersFatty Acid Binding Protein 3FABP3 protein, humanC-Reactive ProteinCreatine Kinase

Autor:innen und Institutionen

  • Division of Clinical Immunology, Department of Internal Medicine, Faculty of Medicine, University of Debrecen, H-4032 Debrecen, Hungary.
  • Doctoral School of Medical Sciences, University of Debrecen, H-4032 Debrecen, Hungary.
  • Department of Neurology, Faculty of Medicine, University of Debrecen, H-4032 Debrecen, Hungary.
  • Department of Clinical Basics, Faculty of Pharmacy, University of Debrecen, H-4032 Debrecen, Hungary.
  • Department of Laboratory Medicine, Faculty of Medicine, University of Debrecen, H-4032 Debrecen, Hungary.
  • Division of Metabolism, Department of Internal Medicine, Faculty of Medicine, University of Debrecen, H-4032 Debrecen, Hungary.

ORCID-Profile: Dorottya Szinay, Katalin Szabó, Béla Nagy, Hajnalka Lőrincz, Mariann Harangi, Zoltán Griger, Melinda Nagy-Vincze

Zitieren

APA

Szinay, D., Szabó, K., Béldi, T., Bencs, V., Csiha, S., Nagy, B., Lőrincz, H., Harangi, M., Griger, Z., & Nagy-Vincze, M. (2026). FABP3, a Candidate Biomarker of Muscle Strength and Myositis Disease Activity in Patients with Idiopathic Inflammatory Myopathies. Biomolecules. https://doi.org/10.3390/biom16101518

Vancouver

Szinay D, Szabó K, Béldi T, Bencs V, Csiha S, Nagy B, et al. FABP3, a Candidate Biomarker of Muscle Strength and Myositis Disease Activity in Patients with Idiopathic Inflammatory Myopathies. Biomolecules. 2026. doi:10.3390/biom16101518

BibTeX
@article{Szinay2026,
  author = {Szinay, Dorottya and Szabó, Katalin and Béldi, Tibor and Bencs, Viktor and Csiha, Sára and Nagy, Béla and Lőrincz, Hajnalka and Harangi, Mariann and Griger, Zoltán and Nagy-Vincze, Melinda},
  title = {FABP3, a Candidate Biomarker of Muscle Strength and Myositis Disease Activity in Patients with Idiopathic Inflammatory Myopathies},
  journal = {Biomolecules},
  year = {2026},
  doi = {10.3390/biom16101518}
}
Kostenlos starten →